• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NC6

NANOLLOSE LIMITED - News & Media

0.00% ! 5.1¢
Market Cap $15.54M  !
Consumer Cyclical Textile Manufacturing
Add to My Watchlist

Nanollose Limited is an Australia-based biomaterials company. The Company is engaged in... Nanollose Limited is an Australia-based biomaterials company. The Company is engaged in commercializing scalable technology to create fibers, fabrics, and other novel materials with minimal environmental impact. Its eco-friendly fermentation process can use agricultural waste and by-products to produce cellulose, a versatile raw material traditionally produced from trees via the wood pulping process. Its products include Nullarbor and Jelli Grow. The Company uses tree-free cellulose as an input for its range of advanced biomaterials, including its Nullarbor fibers, Biollose horticultural medium, and its emerging animal-free and plastic-free leather-like materials. It produces tree-free lyocell fibers for use in textiles, non-woven fabrics and other industrial applications. Its Jelli Grow is an alternative seed germination and plant growing material made from the Company’s tree-free microbial cellulose.More

No News & Media currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.54M
Open High Low Value Volume
5.1¢ 5.1¢ 5.1¢ $236 4.627K

Buyers (Bids)

No. Vol. Price($)
1 55373 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 32705 1
View Market Depth
Last trade - 14.16pm 22/05/2025 (20 minute delay) ?
Last
5.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
5.2¢ 5.2¢ 5.1¢ 77035
Last updated 14.16pm 22/05/2025 ?
NC6 (ASX) Chart

Top Stories

Long dormant Provaris, building a hydrogen tanker, eyes new market: CO2 storage

Provaris Ltd (ASX:PV1), a decidedly unique ASX stock – it's attempting to build a world first hydrogen storage shipping tanker – has made...
An RBA cut was locked in. Beijing’s identical Tuesday cut spotlights larger macro forces An RBA cut was basically guaranteed. But Beijing’s identical Tuesday move spotlights larger macro forces After seeing countries...
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...
Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
Raiden snaps up 75% of Vuzel gold project in Bulgaria as lithium days put to rest Raiden Resources (ASX:RDN) has all but formally pivoted away from lithium with its move to 75% ownership of the Vuzel gold...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.